Literature DB >> 27523002

Radiological and Pathological Correlation in Anti-MDA5 Antibody-positive Interstitial Lung Disease: Rapidly Progressive Perilobular Opacities and Diffuse Alveolar Damage.

Haruka Chino1, Akimasa Sekine, Tomohisa Baba, Tae Iwasawa, Koji Okudela, Tamiko Takemura, Harumi Itoh, Shinji Sato, Yasuo Suzuki, Takashi Ogura.   

Abstract

We herein present the first case of rapidly progressive interstitial lung disease (RP-ILD) with anti-melanoma differentiation-associated protein 5 (MDA5) antibody evaluated by surgical lung biopsy (SLB). High-resolution CT scan revealed perilobular opacities, which rapidly became thicker and formed consolidation, resulting in remarkable loss of lung volume. Specimens taken from SLB revealed membranous organization with alveolar occlusion, dilation of alveolar ducts, and sacs with collapsed alveoli, which are typical features of diffuse alveolar damage (DAD). Rapidly progressive perilobular opacities may be characteristic of RP-ILD with anti-MDA5 antibody and DAD.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27523002     DOI: 10.2169/internalmedicine.55.5774

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  8 in total

1.  Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibody.

Authors:  Lili Jiang; Youlian Wang; Qinglin Peng; Xiaoming Shu; Guochun Wang; Xiaomu Wu
Journal:  Clin Rheumatol       Date:  2019-02-09       Impact factor: 2.980

Review 2.  Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis.

Authors:  Wanlong Wu; Li Guo; Yakai Fu; Kaiwen Wang; Danting Zhang; Wenwen Xu; Zhiwei Chen; Shuang Ye
Journal:  Clin Rev Allergy Immunol       Date:  2021-01-06       Impact factor: 8.667

3.  In reply.

Authors:  Tae Iwasawa; Midori Sato; Takashi Yamaya; Yozo Sato; Takenori Uchida; Hideya Kitamura; Eri Hagiwara; Shigeru Komatsu; Daisuke Utsunomiya; Takashi Ogura
Journal:  Jpn J Radiol       Date:  2020-07-29       Impact factor: 2.374

4.  Interstitial Lung Disease with Anti-melanoma Differentiation-associated Protein 5 Antibody: Rapidly Progressive Perilobular Opacity.

Authors:  Haruka Chino; Akimasa Sekine; Tomohisa Baba; Hideya Kitamura; Tae Iwasawa; Koji Okudela; Tamiko Takemura; Harumi Itoh; Shinji Sato; Yasuo Suzuki; Takashi Ogura
Journal:  Intern Med       Date:  2019-06-07       Impact factor: 1.271

5.  Clinically Amyopathic Dermatomyositis With Rapid Progressive Interstitial Lung Disease Diagnosed in a Patient on Extracorporeal Membrane Oxygenation.

Authors:  Faisal Al-Husayni; Adeeb Munshi; Sultan Qanash; Talal A Shaikhain; Zeyad Alzahrani; Bader Alghamdi
Journal:  Cureus       Date:  2022-08-10

6.  Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis.

Authors:  Noriho Sakamoto; Hiroshi Ishimoto; Shota Nakashima; Hirokazu Yura; Takuto Miyamura; Daisuke Okuno; Atsuko Hara; Takeshi Kitazaki; Tomoyuki Kakugawa; Yuji Ishimatsu; Minoru Satoh; Hiroshi Mukae
Journal:  Intern Med       Date:  2018-11-19       Impact factor: 1.271

Review 7.  Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review.

Authors:  Juan González-Moreno; Manuel Raya-Cruz; Ines Losada-Lopez; Ana Paula Cacheda; Cristina Oliver; Bartomeu Colom
Journal:  Rheumatol Int       Date:  2018-02-07       Impact factor: 2.631

8.  Association of extended myositis panel results, clinical features, and diagnoses: a single-center retrospective observational study.

Authors:  Shamma Ahmad Al Nokhatha; Eman Alfares; Luke Corcoran; Niall Conlon; Richard Conway
Journal:  Rheumatol Int       Date:  2021-10-04       Impact factor: 2.631

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.